Table 5.

Distribution of other diseases among HIV-positive adults newly hospitalized from April to September 2010, IeDEA West Africa Collaboration

		Classification, N (%)a			Diagnosis, N
	N (%)a	AIDS	WHO stage 4	WHO stage 3	Presumptive	Definitive	Suspected IRIS, N	Suspected Adverse effect, N
Total number of patients	824 (100)	445 (100)	388 (100)	232 (100)			45	45
Other diseases
Digestiveb	37 (4.5)				5	32		1
Bronchopulmonaryc	2 (0.2)				1	1
Cardiovasculard	53 (6.4)				15	37		3
Neurologice	28 (3.4)				24	4		4
Psychiatricf	9 (1.1)				4	5		1
Renalg	41 (5.0)		12 (3.1)		11	30		2
Genital	11 (1.3)				2	9
Osteo-articular	5 (0.6)				2	3
Cutaneous	14 (1.7)				3	11		8i
Endocrineh	6 (0.7)				1	5
Ocular	1 (0.1)				–	1
Trauma	1 (0.1)				1	–

^aSeveral illnesses may have occurred during the hospitalization of a given patient;

^bdigestive: gastroduodenal ulcer (n=15), gastritis (n=3), oesophagitis (n=4), duodenogastric reflux (n=3), appendicitis/peritonitis (n=3), cholecystitis (n=6), calculus of gallbladder (n=2), digestive haemorragiae (n=1), functional intestinal disorder (n=7), anal fistula (n=1);

^cbronchopulmonary: pleuresia (n=1), pneumothorax (n=1);

^dcardiovascular: stroke (n=19), heart failure (n=11), pericarditis (n=7), high blood pressure (n=6), peripheral venous disease (n=3), pulmonary embolism (n=2);

^eneurologic: peripheral neuropathy [n=12 including four suspected adverse effects of zidovudine (n=1), d4T (n=3)], encephalitis (n=8), cerebral abscess (n=7), Guillain-Barre syndrome (n=1);

^fpsychiatric: delirium ascribed to efavirenz (n=1);

^grenal: renal insufficiency (n=24 including two suspected adverse effect of tenofovir), HIV associated nephropathy (n=12), glomerular disease (n=4), ureteral lithiasis (n=1);

^hendocrine: diabetes (n=4), thyroid, multinodular goitre (n=1), surrenal insufficiency (n=1);

ⁱtoxidermia (n=8 including four cases ascribed to nevirapine and one to isoniazid).